News | Cath Lab | April 25, 2022

NewYork-Presbyterian Hudson Valley Hospital Launches Interventional Cardiology Program and Opens State-of-the-Art Cardiac Catheterization Lab

The new interventional cardiology program will provide advanced cardiac intervention services, expanding access to the hospital’s team of leading specialists and expert care.
 

Celebrating the opening of new Interventional Cardiology Suite at NewYork-Presbyterian Hudson Valley Hospital

Celebrating the opening of new Interventional Cardiology Suite at NewYork-Presbyterian Hudson Valley Hospital


April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology program and the opening of its new cardiac catheterization laboratory, designed to support cardiac health and bring world-class interventional cardiology care to the Hudson Valley and upper Westchester region.

“NewYork-Presbyterian Hudson Valley Hospital and NewYork-Presbyterian Medical Group Hudson Valley cardiologists have been caring for our community’s hearts for decades,” said Stacey Petrower, president of NewYork-Presbyterian Hudson Valley Hospital. “We pride ourselves on serving our community, and are pleased to now be providing emergent life-saving intervention, in addition to diagnostic and preventive medical procedures, close to home.”

Dr. Giora Weisz
Dr. Giora Weisz, medical director of interventional cardiology at NewYork-Presbyterian Hudson Valley Hospital and an associate professor of medicine at Columbia University Vagelos College of Physicians and Surgeons.

“We look forward to further improving the cardiac care for residents of our surrounding communities and providing comprehensive on-site care for patients already treated at our hospital,” said Dr. Giora Weisz, medical director of interventional cardiology at NewYork-Presbyterian Hudson Valley Hospital and an associate professor of medicine at Columbia University Vagelos College of Physicians and Surgeons. “When it comes to cardiac emergencies, time is muscle. Having a catheterization lab close to home means patients will have speedier access to expert care, and that leads to better outcomes, especially for those experiencing a life-threatening event such as a heart attack.”

The interventional cardiology program provides a variety of emergent procedures, including cardiac angioplasty to improve blood flow in narrow or blocked arteries for patients experiencing a heart attack or chest pain. Advanced cardiac services include diagnostic cardiac catheterization (a procedure in which a catheter is guided through a blood vessel in the heart to diagnose certain heart conditions) and minimally invasive procedures to open clogged arteries. These include percutaneous coronary intervention (PCI, also known as ‘balloon and stent procedure’) and endovascular peripheral arterial revascularization, as well as electrophysiology (EP) procedure services to restore heart rhythms. The interventional cardiology program is equipped with the most up to date, state-of-the-art equipment including novel catheters to image the blood vessels from the inside. Additionally, physicians provide pacemaker and defibrillator implantation for treatment of arrhythmias.

NewYork-Presbyterian Hudson Valley Hospital’s interventional cardiology program will be open for emergent cases 24 hours a day, seven days a week, and will have a structured schedule for diagnostic and non-emergent procedures. Patients who may require cardiac surgery will have easy access to surgeons at NewYork-Presbyterian/Columbia University Irving Medical Center, establishing seamless team-oriented continuity of care.

The 8,500-square-foot facility was designed in collaboration with Jeffrey Berman Architect, OLA Consulting Engineers and Severud Associates, and is part of a broader initiative to enhance cardiac services across NewYork-Presbyterian's health system.

For more information: https://www.nyp.org/hudsonvalley


Related Content

News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
Subscribe Now